
Background: Adverse drug reactions (ADR) are rated as fifth leading cause of death and accounts for approximately 5% of all hospital admissions. ADR monitoring plays a major role in pharmacotherapy, decision making in individual reports, regional, national and international programs. ADR monitoring can help to ensure that patients obtain safe and efficacious products. With the existing limited and inconsistent ADR data, more studies at institutional level can generate valid ADR information. Hence, this prospective study was designed to evaluate the pattern of ADRs in a tertiary care hospital. Methods: In our study all spontaneously reported ADRs were evaluated based on data collected from various clinical departments. Suspected drugs were coded according to WHO-anatomical therapeutic chemical classification. The organ system involvement for ADR was labeled as per WHO-ADR terminology. ADRs were also categorized into two types – augmented (A) and bizarre (B) as per Rawlins and Thompson classification. Causality Assessment was performed using WHO Uppsala Monitoring Centre (UMC) Causality Assessment Criteria. Severity of the identified ADRs was assessed using modified Hartwig’s criteria. The preventability of the reactions was assessed according to Schumock and Thornton’s criteria. Results: Out of all ADRs, 31.68% was type-A reactions while 68.32 % was type-B reactions. The commonly involved organ system was skin and appendages 56 (34.78%). The major causative drug class was antimicrobials (43.02%). The causality of most ADRs was “probable” (60.25%) followed by “possible” (34.78%). Most of the ADRs were moderate in nature (45.96%). Around 42.24% of the reported ADRs were definitely preventable. Conclusion: Adverse drug reaction is one of the leading cause of hospital based admissions. Practicing rational use of medicines and avoiding medication errors, a major fraction of ADRs can be prevented. Proper awareness among health care personnel and involvement of drug controlling authorities can minimize this grave situation.
Background: Adverse drug reactions (ADR) are rated as fifth leading cause of death and accounts for approximately 5% of all hospital admissions. ADR monitoring plays a major role in pharmacotherapy, decision making in individual reports, regional, national and international programs. ADR monitoring can help to ensure that patients obtain safe and efficacious products. With the existing limited and inconsistent ADR data, more studies at institutional level can generate valid ADR information. Hence, this prospective study was designed to evaluate the pattern of ADRs in a tertiary care hospital. Methods: In our study all spontaneously reported ADRs were evaluated based on data collected from various clinical departments. Suspected drugs were coded according to WHO-anatomical therapeutic chemical classification. The organ system involvement for ADR was labeled as per WHO-ADR terminology. ADRs were also categorized into two types – augmented (A) and bizarre (B) as per Rawlins and Thompson classification. Causality Assessment was performed using WHO Uppsala Monitoring Centre (UMC) Causality Assessment Criteria. Severity of the identified ADRs was assessed using modified Hartwig’s criteria. The preventability of the reactions was assessed according to Schumock and Thornton’s criteria. Results: Out of all ADRs, 31.68% was type-A reactions while 68.32 % was type-B reactions. The commonly involved organ system was skin and appendages 56 (34.78%). The major causative drug class was antimicrobials (43.02%). The causality of most ADRs was “probable” (60.25%) followed by “possible” (34.78%). Most of the ADRs were moderate in nature (45.96%). Around 42.24% of the reported ADRs were definitely preventable. Conclusion: Adverse drug reaction is one of the leading cause of hospital based admissions. Practicing rational use of medicines and avoiding medication errors, a major fraction of ADRs can be prevented. Proper awareness among health care personnel and involvement of drug controlling authorities can minimize this grave situation.
Adverse drug reaction, Pharmacovigilance, Medication errors, Central Drugs Standard Control Organisation
Adverse drug reaction, Pharmacovigilance, Medication errors, Central Drugs Standard Control Organisation
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 0 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
